Literature DB >> 32167983

Opioid Stewardship Program and Postoperative Adverse Events: A Difference-in-differences Cohort Study.

Antje M Barreveld1, Robert J McCarthy, Nabil Elkassabany, Edward R Mariano, Brian Sites, Roshni Ghosh, Asokumar Buvanendran.   

Abstract

BACKGROUND: A 6-month opioid use educational program consisting of webinars on pain assessment, postoperative and multimodal pain opioid management, safer opioid use, and preventing addiction coupled with on-site coaching and monthly assessments reports was implemented in 31 hospitals. The authors hypothesized the intervention would measurably reduce and/or prevent opioid-related harm among adult hospitalized patients compared to 33 nonintervention hospitals.
METHODS: Outcomes were extracted from medical records for 12 months before and after the intervention start date. Opioid adverse events, evaluated by opioid overdose, wrong substance given or taken in error, naloxone administration, and acute postoperative respiratory failure causing prolonged ventilation were the primary outcomes. Opioid use in adult patients undergoing elective hip or knee arthroplasty or colorectal procedures was also assessed. Differences-in-differences were compared between intervention and nonintervention hospitals.
RESULTS: Before the intervention, the incidence ± SD of opioid overdose, wrong substance given, or substance taken in error was 1 ± 0.5 per 10,000 discharges, and naloxone use was 117 ± 13 per 10,000 patients receiving opioids. The incidence of respiratory failure was 42 ± 10 per 10,000 surgical discharges. A difference-in-differences of -0.2 (99% CI, -1.1 to 0.6, P = 0.499) per 10,000 in opioid overdose, wrong substance given, or substance taken in error and -13.6 (99% CI, -29.0 to 0.0, P = 0.028) per 10,000 in respiratory failure was observed postintervention in the intervention hospitals; however, naloxone administration increased by 15.2 (99% CI, 3.8 to 30.0, P = 0.011) per 10,000. Average total daily opioid use, as well as the fraction of patients receiving daily opioid greater than 90 mg morphine equivalents was not different between the intervention and nonintervention hospitals.
CONCLUSIONS: A 6-month opioid educational intervention did not reduce opioid adverse events or alter opioid use in hospitalized patients. The authors' findings suggest that despite opioid and multimodal analgesia awareness, limited-duration educational interventions do not substantially change the hospital use of opioid analgesics. : WHAT WE ALREADY KNOW ABOUT THIS TOPIC: Education may promote safer opioid use in hospitals WHAT THIS ARTICLE TELLS US THAT IS NEW: The investigators conducted a difference-in-differences analysis before and after implementation of opioid training in 31 intervention hospitals and 33 nonintervention hospitalsThe 6-month-long opioid education consisted of webinars on pain assessment, multimodal analgesia, and safer opioid useThe educational initiative did not substantively change opioid use.

Entities:  

Year:  2020        PMID: 32167983     DOI: 10.1097/ALN.0000000000003238

Source DB:  PubMed          Journal:  Anesthesiology        ISSN: 0003-3022            Impact factor:   7.892


  1 in total

1.  Effect of Scalp Nerve Block Combined with Intercostal Nerve Block on the Quality of Recovery in Patients with Parkinson's Disease after Deep Brain Stimulation: Protocol for a Randomized Controlled Trial.

Authors:  Ying Sheng; Hui Wang; Xinning Chang; Peipei Jin; Shengwei Lin; Shuang Qian; Jian Xie; Wenbin Lu; Xiya Yu
Journal:  Brain Sci       Date:  2022-07-29
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.